Prognostic differences between pre-existing atrial fibrillation in chronic kidney disease and new-onset atrial fibrillation at hemodialysis initiation: a retrospective single-center cohort study
PLOS ONE · 25.03.2025 · 20 (3) · e0320336
DOI: 10.1371/journal.pone.0320336 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS ONE, online erschienen am 25.03.2025. Verfasst von Tomohisa Tsuyuki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Renal Dialysis, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atrial fibrillation (AF) can develop in patients with chronic kidney disease. However, the impact of new-onset AF in patients who are initiated on hemodialysis remains unclear. We categorized 254 patients who were started on hemodialysis into three groups: those with pre-existing AF, those with new-onset AF, and those without AF. Statistical analyses were performed to evaluate the associations between patient characteristics and survival outcomes. AF was observed in 42 patients (16.5%), of whom 19 (7.5%) had pre-existing AF and 23 (9.1%) developed new-onset AF at the initiation of hemodialysis. Multivariate logistic regression models showed that only low serum albumin levels were associated with AF (P = 0.04). Age- and other factors-adjusted multivariable Cox regression models indicated that AF, particularly pre-existing AF, was an independent risk factor for death after dialysis initiation (hazard ratio [HR]: 2.28, 95% confidence interval [CI]: 1.39–3.74, P = 0.001; HR: 3.05, 95% CI: 1.64–5.66, P = 0.004, respectively). However, new-onset AF was not significantly associated with mortality (HR: 1.43, 95% CI: 0.74–2.78, P = 0.28). These findings suggest that pre-existing AF before hemodialysis initiation has a crucial impact on patient prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Department of Nephrology, Nagasaki Harbor Medical Center, Nagasaki, Japan.
- Department of Nephrology, Japan Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
- Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
ORCID-Profile: Mineaki Kitamura
Zitieren
APA
Tsuyuki, T., Kitamura, M., Fukuda, H., Ishii, T., Torigoe, K., Yamashita, H., Takazono, T., Sakamoto, N., Mukae, H., & Nishino, T. (2025). Prognostic differences between pre-existing atrial fibrillation in chronic kidney disease and new-onset atrial fibrillation at hemodialysis initiation: a retrospective single-center cohort study. PLOS ONE, 20(3), e0320336. https://doi.org/10.1371/journal.pone.0320336
Vancouver
Tsuyuki T, Kitamura M, Fukuda H, Ishii T, Torigoe K, Yamashita H, et al. Prognostic differences between pre-existing atrial fibrillation in chronic kidney disease and new-onset atrial fibrillation at hemodialysis initiation: a retrospective single-center cohort study. PLOS ONE. 2025;20(3):e0320336. doi:10.1371/journal.pone.0320336
BibTeX
@article{Tsuyuki2025,
author = {Tsuyuki, Tomohisa and Kitamura, Mineaki and Fukuda, Haruka and Ishii, Takuma and Torigoe, Kenta and Yamashita, Hiroshi and Takazono, Takahiro and Sakamoto, Noriho and Mukae, Hiroshi and Nishino, Tomoya},
title = {Prognostic differences between pre-existing atrial fibrillation in chronic kidney disease and new-onset atrial fibrillation at hemodialysis initiation: a retrospective single-center cohort study},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {3},
pages = {e0320336},
doi = {10.1371/journal.pone.0320336}
}
EUVIMED